Analysts tracking the tnya stock price forecast cite robust demand within its industry segment, with a projected Q3 revenue increase of 5.5%, giving the stock a medium-term upside potential toward $19. “We view favorable trends on cardiac biomarkers and uninterpretable protein expression data as the most likely scenario,” Ulz added. “We believe investors would view the data as positive and suggestive of benefit… Under this scenario we would expect TNYA shares to trade up +100%.” Find stocks with ease across diverse datasets and filters Some market strategists project in their tnya stock price forecast that breaking above $18.60 could trigger a technical rally, extending gains toward $20.25 if macro data supports risk-on sentiment.